| A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases MRS Siddiqui, C Simillis, C Hunter, M Chand, J Bhoday, A Garant, ... British journal of cancer 116 (12), 1513-1519, 2017 | 133 | 2017 |
| Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: a systematic review A Garant, C Guilbault, T Ekmekjian, Z Greenwald, P Murgoi, T Vuong Critical reviews in oncology/hematology 120, 86-92, 2017 | 113 | 2017 |
| Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment CJ Hunter, A Garant, T Vuong, G Artho, R Lisbona, P Tekkis, M Abulafi, ... Annals of surgical oncology 19, 1199-1205, 2012 | 96 | 2012 |
| A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer DM Routman, A Garant, SC Lester, CN Day, WS Harmsen, CT Sanheuza, ... Advances in radiation oncology 4 (1), 63-69, 2019 | 87 | 2019 |
| Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer Y Zhang, J Schoenhals, A Christie, O Mohamad, C Wang, I Bowman, ... International Journal of Radiation Oncology* Biology* Physics 105 (2), 367-375, 2019 | 75 | 2019 |
| EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors? A Paliga, R Onerheim, A Gologan, G Chong, A Spatz, T Niazi, A Garant, ... British journal of cancer 107 (11), 1864-1868, 2012 | 61 | 2012 |
| Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer I Yau, T Vuong, A Garant, T Ducruet, P Doran, S Faria, S Liberman, ... International Journal of Radiation Oncology* Biology* Physics 74 (5), 1481-1486, 2009 | 56 | 2009 |
| A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy A Balagopal, D Nguyen, H Morgan, Y Weng, M Dohopolski, MH Lin, ... Medical image analysis 72, 102101, 2021 | 55 | 2021 |
| Phase II trial of stereotactic ablative radiation for oligoprogressive metastatic kidney cancer R Hannan, M Christensen, H Hammers, A Christie, B Paulman, D Lin, ... European urology oncology 5 (2), 216-224, 2022 | 41 | 2022 |
| Psa-net: Deep learning–based physician style–aware segmentation network for postoperative prostate cancer clinical target volumes A Balagopal, H Morgan, M Dohopolski, R Timmerman, J Shan, DF Heitjan, ... Artificial Intelligence in Medicine 121, 102195, 2021 | 41 | 2021 |
| Image guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer A Garant, S Magnan, S Devic, AG Martin, M Boutros, CA Vasilevsky, ... International Journal of Radiation Oncology* Biology* Physics 105 (5), 1005-1011, 2019 | 41 | 2019 |
| Stereotactic Ablative Radiation for Systemic Therapy–naïve Oligometastatic Kidney Cancer R Hannan, M Christensen, A Christie, A Garant, I Pedrosa, L Robles, ... European urology oncology 5 (6), 695-703, 2022 | 31 | 2022 |
| Phase 2 trial of stereotactic ablative radiotherapy for patients with primary renal cancer R Hannan, MF McLaughlin, LM Pop, I Pedrosa, P Kapur, A Garant, C Ahn, ... European urology 84 (3), 275-286, 2023 | 27 | 2023 |
| Stereotactic ablative radiation therapy for oligoprogressive renal cell carcinoma JE Schoenhals, O Mohamad, A Christie, Y Zhang, D Li, N Singla, ... Advances in Radiation Oncology 6 (5), 100692, 2021 | 27 | 2021 |
| MORPHEUS phase II–III study: a pre-planned interim safety analysis and preliminary results A Garant, CA Vasilevsky, M Boutros, F Khosrow-Khavar, P Kavan, H Diec, ... Cancers 14 (15), 3665, 2022 | 24 | 2022 |
| A comparison of patient-reported health-related quality of life during proton versus photon chemoradiation therapy for esophageal cancer A Garant, TJ Whitaker, GM Spears, DM Routman, WS Harmsen, TJ Wilhite, ... Practical radiation oncology 9 (6), 410-417, 2019 | 21 | 2019 |
| Hydrogel spacer rectal wall infiltration associated with severe rectal injury and related complications after dose intensified prostate cancer stereotactic ablative radiation … MF McLaughlin, MR Folkert, RD Timmerman, R Hannan, A Garant, ... Advances in Radiation Oncology 6 (4), 100713, 2021 | 20 | 2021 |
| SABR for high-risk prostate cancer: A prospective multilevel MRI-based dose escalation trial R Hannan, S Salamekh, NB Desai, A Garant, MR Folkert, DN Costa, ... International Journal of Radiation Oncology* Biology* Physics 113 (2), 290-301, 2022 | 17 | 2022 |
| Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial A Garant, P Kavan, AG Martin, L Azoulay, V Vendrely, C Lavoie, ... Radiotherapy and Oncology 155, 237-245, 2021 | 16 | 2021 |
| Metastasis-directed radiation therapy after radical cystectomy for bladder cancer AF Miranda, JM Howard, M McLaughlin, X Meng, T Clinton, Ö Şanli, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 790. e1-790. e7, 2021 | 15 | 2021 |
